Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades. Health Insurance and Managed Care, Prices (Fares, Fees and Rates), Drugs (Pharmaceuticals), Cancer, Pancreatic Cancer, Clinical Trials, Elderly, Immunotherapy, Longevity, Institute for Clinical and Economic Review, Revolution Medicines Inc Read More
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
